C07C 235/56
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
C07C235/56 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 272 US grants and 252 published applications in this corpus.
Search patents in C07C- Granted patents
- 272
- Published applications
- 252
- Assignees
- 180
- Inventors
- 870
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 7 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 9 | 0 |
| 1999 | 8 | 0 |
| 2000 | 11 | 0 |
| 2001 | 9 | 3 |
| 2002 | 19 | 14 |
| 2003 | 16 | 25 |
| 2004 | 19 | 12 |
| 2005 | 5 | 10 |
| 2006 | 8 | 9 |
| 2007 | 3 | 10 |
| 2008 | 7 | 8 |
| 2009 | 7 | 11 |
| 2010 | 9 | 13 |
| 2011 | 3 | 9 |
| 2012 | 11 | 9 |
| 2013 | 10 | 17 |
| 2014 | 7 | 9 |
| 2015 | 11 | 11 |
| 2016 | 8 | 14 |
| 2017 | 7 | 7 |
| 2018 | 7 | 10 |
| 2019 | 7 | 4 |
| 2020 | 8 | 10 |
| 2021 | 5 | 12 |
| 2022 | 8 | 10 |
| 2023 | 5 | 4 |
| 2024 | 3 | 5 |
| 2025 | 6 | 5 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Aug 2026US 12,698,255 B2ImmuneBridge Inc.
- EP2 antagonist19 May 2026US 12,630,510 B2Ono Pharmaceutical Co., Ltd.
- Cocrystal comprising camostat and niclosamide, pharmaceutical composition comprising same and preparation method therefor20 Jan 2026US 12,527,762 B2Imdpharm Inc.
- Benzamide derivatives as cGAS-sting pathway agonists30 Dec 2025US 12,509,436 B2Baruch S. Blumberg Institute
- Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors25 Nov 2025US 12,479,797 B2Jubilant Epicore LLC
- Long-chain alkenyloxy-substituted benzoyl derivative and oligonucleotide synthesis method using same17 Sep 2026US 2026/0274885 A1SPERA PHARMA, Inc.
- Oligo-benzamide analogs and their use in cancer treatment2 Oct 2025US 2025/0304528 A1Board of Regents, The University of Texas System
- Novel inhibitors of guanosine monophosphate synthetase as therapeutic agents21 Aug 2025US 2025/0263383 A1University of Southern California
- Compositions, methods, and development of arid4b inhibitors27 Mar 2025US 2025/0099405 A1The George Washington University
- Naphthalene and quinoline analogs as rxfp1 agonists27 Mar 2025US 2025/0100960 A1Bristol-Myers Squibb Company
Most cited
By later US patents
- Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity167US 5,919,970 AAllergan Sales, Inc. · 1999
- Compounds and compositions for delivering active agents116US 5,773,647 AEmisphere Technologies, Inc. · 1998
- Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors105US 5,712,298 AByk Gulden Lomberg Chemische Fabrik GmbH · 1998
- Phenylcarboxamide compounds which have useful pharmaceutical activity83US 5,340,827 ACelltech Limited · 1994
- Stilbene derivatives as anticancer agents78US 5,430,062 AResearch Corporation Technologies, Inc. · 1995